Biohit Oyj - Managers' Transactions, April 4, 2017 at 11:15 am local time (EEST)
Biohit Oyj has received the following notification.
Person subject to the notification requirement |
Name: |
Euroclone Spa |
Legal Person |
Position: |
Closely associated person |
|
Person discharging managerial responsibilities in issuer |
Name: |
Aiolfi, Franco |
Position: |
Member of the Board/Deputy member |
|
|
|
|
Initial Notification |
|
Reference number: |
74370089ATTSNBXJVT29_20170404092720_6 |
|
|
|
Issuer |
Name: |
Biohit Oyj |
LEI: |
74370089ATTSNBXJVT29 |
|
|
|
Transaction details |
Transaction date: |
2017-03-30 |
Venue: |
NASDAQ HELSINKI LTD (XHEL) |
Nature of the transaction: |
Disposal |
|
Instrument: |
Share |
ISIN: |
FI0009005482 |
|
Volume: |
1233 |
Unit price: |
5,57000 Euro |
Volume: |
680 |
Unit price: |
5,59000 Euro |
Volume: |
260 |
Unit price: |
5,60000 Euro |
Volume: |
268 |
Unit price: |
5,59000 Euro |
Volume: |
398 |
Unit price: |
5,54000 Euro |
Volume: |
500 |
Unit price: |
5,53000 Euro |
Volume: |
1159 |
Unit price: |
5,50000 Euro |
Volume: |
110 |
Unit price: |
5,50000 Euro |
Volume: |
110 |
Unit price: |
5,50000 Euro |
Volume: |
750 |
Unit price: |
5,50000 Euro |
Volume: |
30 |
Unit price: |
5,50000 Euro |
Volume: |
1102 |
Unit price: |
5,50000 Euro |
Volume: |
3400 |
Unit price: |
5,50000 Euro |
Volume: |
1135 |
Unit price: |
5,50000 Euro |
Volume: |
1000 |
Unit price: |
5,50000 Euro |
Volume: |
2200 |
Unit price: |
5,50000 Euro |
Volume: |
35 |
Unit price: |
5,50000 Euro |
Volume: |
35 |
Unit price: |
5,50000 Euro |
Volume: |
500 |
Unit price: |
5,50000 Euro |
Volume: |
251 |
Unit price: |
5,50000 Euro |
Volume: |
36 |
Unit price: |
5,50000 Euro |
Volume: |
4389 |
Unit price: |
5,50000 Euro |
Volume: |
419 |
Unit price: |
5,50000 Euro |
|
Aggregated transactions |
Volume: |
20000 |
Volume weighted average price: |
5.51143 Euro |
|
|
|
Transaction details |
Transaction date: |
2017-03-31 |
Venue: |
NASDAQ HELSINKI LTD (XHEL) |
Nature of the transaction: |
Disposal |
|
Instrument: |
Share |
ISIN: |
FI0009005482 |
|
Volume: |
28 |
Unit price: |
5,51000 Euro |
Volume: |
80 |
Unit price: |
5,51000 Euro |
Volume: |
11 |
Unit price: |
5,51000 Euro |
Volume: |
100 |
Unit price: |
5,50000 Euro |
Volume: |
26 |
Unit price: |
5,51000 Euro |
Volume: |
1262 |
Unit price: |
5,50000 Euro |
Volume: |
300 |
Unit price: |
5,50000 Euro |
Volume: |
71 |
Unit price: |
5,50000 Euro |
Volume: |
926 |
Unit price: |
5,50000 Euro |
Volume: |
1 |
Unit price: |
5,50000 Euro |
|
Aggregated transactions |
Volume: |
2805 |
Volume weighted average price: |
5.50052 Euro |
|
|
|
Transaction details |
Transaction date: |
2017-04-03 |
Venue: |
NASDAQ HELSINKI LTD (XHEL) |
Nature of the transaction: |
Disposal |
|
Instrument: |
Share |
ISIN: |
FI0009005482 |
|
Volume: |
452 |
Unit price: |
5,50000 Euro |
|
Aggregated transactions |
Volume: |
452 |
Volume weighted average price: |
5.50000 Euro |
Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com